documents
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
14 rows where docket_id = "FDA-2014-D-1856" sorted by posted_date descending
This data as json, CSV (advanced)
Suggested facets: subtype, posted_date, posted_month, comment_start_date, comment_end_date, open_for_comment, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)
document_type 3
agency_id 1
- FDA 14
| id | agency_id | docket_id | title | document_type | subtype | posted_date ▲ | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2014-D-1856-0161 | FDA | None FDA-2014-D-1856 | Testimony from Paul Cederna (PSF) | Other | Testimony | 2016-10-19T04:00:00Z | 2016 | 10 | 2016-10-19T04:00:00Z | 2016-10-19T21:02:50Z | 0 | 0 | 0900006482278d7b | ||
| FDA-2014-D-1856-0159 | FDA | None FDA-2014-D-1856 | Testimony from Scot Glasberg | Other | Testimony | 2016-10-19T04:00:00Z | 2016 | 10 | 2016-10-19T04:00:00Z | 2016-10-19T20:36:21Z | 0 | 0 | 0900006482278d79 | ||
| FDA-2014-D-1856-0153 | FDA | None FDA-2014-D-1856 | Testimony from Rebecca Baergen (Alston & Bird LLP) | Other | Testimony | 2016-10-19T04:00:00Z | 2016 | 10 | 2016-10-19T04:00:00Z | 2016-10-19T20:26:05Z | 0 | 0 | 0900006482277bdf | ||
| FDA-2014-D-1856-0160 | FDA | None FDA-2014-D-1856 | Testimony from Peter Rubin (ASPS) | Other | Testimony | 2016-10-19T04:00:00Z | 2016 | 10 | 2016-10-19T04:00:00Z | 2016-10-19T21:01:36Z | 0 | 0 | 090000648227896a | ||
| FDA-2014-D-1856-0087 | FDA | None FDA-2014-D-1856 | Write-In Campaign #2 (Multiple Submitters 13) Form Letter Comment | Other | Form Letter | 2016-04-27T04:00:00Z | 2016 | 4 | 2016-04-27T04:00:00Z | 2016-04-27T14:01:02Z | 0 | 0 | 0900006481f67919 | ||
| FDA-2014-D-1856-0086 | FDA | None FDA-2014-D-1856 | Draft Guidances Relating to the Regulation of Human Cells, Tissues, and Cellular and Tissue-Based Products; Extension of Comment Periods | Proposed Rule | Extension of Comment Period | 2016-04-22T04:00:00Z | 2016 | 4 | 2016-04-22T04:00:00Z | 2016-09-28T03:59:59Z | 2016-10-20T01:00:57Z | 2016-09366 | 0 | 0 | 0900006481f83c8e |
| FDA-2014-D-1856-0083 | FDA | None FDA-2014-D-1856 | Write-In Campaign #1 (Multiple Submitters 17) Form Letter Comment | Other | Form Letter | 2016-04-13T04:00:00Z | 2016 | 4 | 2015-10-30T04:00:00Z | 2016-04-30T03:59:59Z | 2016-04-13T19:47:11Z | 0 | 0 | 0900006481f2eef7 | |
| FDA-2014-D-1856-0061 | FDA | None FDA-2014-D-1856 | Human Cells, Tissues, and Cellular and Tissue-Based Products From Adipose Tissue: Regulatory Considerations; Draft Guidance for Industry; Reopening of the Comment Period | Proposed Rule | Reopening of Comment Period | 2015-10-30T04:00:00Z | 2015 | 10 | 2015-10-30T04:00:00Z | 2016-04-30T03:59:59Z | 2024-11-07T23:24:13Z | 2015-27706 | 1 | 0 | 0900006481cfc915 |
| FDA-2014-D-1856-0055 | FDA | None FDA-2014-D-1856 | Request to Extend Comment Period from Association of Organ Procurement Organizations | Other | Request for Extension | 2015-02-27T05:00:00Z | 2015 | 2 | 2015-02-27T05:00:00Z | 2015-02-27T20:39:52Z | 0 | 0 | 0900006481a1f1d1 | ||
| FDA-2014-D-1856-0005 | FDA | None FDA-2014-D-1856 | Reference 2 Brown et al., Basic Science Review on Adipose Tissue for Clinicians re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002 | Supporting & Related Material | Background Material | 2014-12-24T05:00:00Z | 2014 | 12 | 2015-01-02T15:19:45Z | 0 | 0 | 0900006481991c17 | |||
| FDA-2014-D-1856-0002 | FDA | None FDA-2014-D-1856 | Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) From Adipose Tissue: Regulatory Considerations; Draft Guidance for Industry | Other | Guidance | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2024-11-12T05:31:43Z | 1 | 0 | 0900006481991c12 | ||
| FDA-2014-D-1856-0004 | FDA | None FDA-2014-D-1856 | Reference 1 Chapter 6 Adipose Tissue re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002 | Supporting & Related Material | Background Material | 2014-12-24T05:00:00Z | 2014 | 12 | 2015-01-02T15:19:44Z | 0 | 0 | 0900006481991c15 | |||
| FDA-2014-D-1856-0001 | FDA | None FDA-2014-D-1856 | Human Cells, Tissues, and Cellular and Tissue-Based Products From Adipose Tissue: Regulatory Considerations; Draft Guidance for Industry; Availability | Proposed Rule | Request for Comment | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T05:00:00Z | 2015-02-24T04:59:59Z | 2015-02-24T03:13:21Z | 2014-30142 | 0 | 0 | 09000064819914d3 |
| FDA-2014-D-1856-0003 | FDA | None FDA-2014-D-1856 | Reference List re Human Cells Tissues, and Cellular and Tissue Based Products HCTPs From Adipose Tissue: Regulatory Consideration; Draft Guidance for Industry, FDA-2014-D-1856-0002 | Supporting & Related Material | Background Material | 2014-12-24T05:00:00Z | 2014 | 12 | 2014-12-24T20:22:25Z | 0 | 0 | 0900006481991c14 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE documents (
id TEXT PRIMARY KEY,
agency_id TEXT,
docket_id TEXT REFERENCES dockets(id),
title TEXT,
document_type TEXT,
subtype TEXT,
posted_date TEXT,
posted_year INTEGER,
posted_month INTEGER,
comment_start_date TEXT,
comment_end_date TEXT,
last_modified TEXT,
fr_doc_num TEXT,
open_for_comment INTEGER,
withdrawn INTEGER,
object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;